Oncolytics Biotech, Inc.

Twitter LinkedIn
  • Home
  • About
    • Our Company
    • Management Team
    • Board of Directors
  • Technology
    • What is Pelareorep?
    • What Does Pelareorep Do?
    • Delivery
    • Intellectual Property
    • Posters & Publications
    • Manufacturing
  • Clinical Trials
    • Clinical Development Plan
    • Collaborators
    • Pipeline
  • Media
    • Press Releases
    • Insights
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Information
    • Filings & Financials
    • Corporate Governance
    • FAQs
    • Email Alerts
    • IR Contacts
  • Contact
  • Careers

News

Media

Media

  • Press Releases
  • Insights
May 5, 2008

Oncolytics Biotech Inc. Announces Details of 2008 Annual Shareholder Meeting

Mar 18, 2008

Oncolytics Biotech Inc. Announces Issuance of 26th U.S. Patent

Mar 17, 2008

Oncolytics Biotech Inc. Announces Publication of Research on Immune Response to REOLYSIN(R) during a Phase I Clinical Trial

Mar 13, 2008

Oncolytics Biotech Inc. Collaborators to Present Reovirus Research at AACR Annual Meeting

Mar 10, 2008

Media Advisory - Oncolytics Biotech Inc. to Present at BioSquare 2008

Mar 6, 2008

Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007

Feb 21, 2008

Media Advisory - Oncolytics Biotech Inc. to Present at Oncology Biologics Development Primer

Feb 6, 2008

Media Advisory - Oncolytics Biotech Inc. to Present at Bio CEO & Investor Conference

Feb 4, 2008

Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy

Jan 31, 2008

Oncolytics Biotech Inc. Proceeds to Full Enrolment in U.S. Phase II Sarcoma Clinical Trial

    • 1...
    • 47
    • 48
    • 49
    • 50
    • 51
    • 52
    • 53
    • 54
    • 55
    • 56
    • ...58
    © 2022 Oncolytics Biotech, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap